Home
    Disclaimer
    Methyprylon molecular structure

    Methyprylon Stats & Data

    Noludar
    PubChem
    MW183.25
    FormulaC10H17NO2
    LogP0.8
    IUPAC3,3-diethyl-5-methylpiperidine-2,4-dione
    InChIKeySIDLZWOQUZRBRU-UHFFFAOYSA-N
    Chemical Class Benzodiazepine
    Psychoactive Class Depressant

    Pharmacology

    DrugBank
    Half-life 6-16 hours Protein binding 60% State Solid

    Description

    Methyprylon is a sedative of the piperidinedione derivative family that was previously used for the treatment of insomnia. However, with the introduction of newer drugs with fewer side effects, such as benzodiazepines, the clinical use of methyprylon is now limited. Methyprylon was withdrawn from the U.S. market in June 1965 and the Canadian market in September 1990 due to adverse events.

    Mechanism of Action

    Methyprylon binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.

    Pharmacodynamics

    Methyprylon, a piperidinedione CNS depressant, is close to barbituric acid in structure, but different enough to be called a "non-barbiturate" sedative-hynotic. Methyprylon is used for insomnia and daytime tension. Methyprylon depresses the activity of muscle tissues, the heart, and the respiratory system.

    Metabolism

    Hepatic. Methyprylon is almost completely metabolized.

    Indication

    For the treatment of insomnia.

    Toxicity

    PubChem DrugBank

    Methyprylon binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.

    Carcinogenicity

    No indication of carcinogenicity to humans (not listed by IARC).

    Toxicity (DrugBank)

    Symptoms of overdose include excitation and convulsions.

    Health effects (PubChem excerpts)

    They cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive.

    Effect Profile

    Curated
    Benzodiazepine 4.7

    Strong euphoria with low anxiolysis, sedation, and cognitive impairment

    Anxiolysis×3
    3
    Sedation / Relaxation×2
    3
    Motor / Cognitive Impairment×1
    2
    Euphoria / Mood Lift×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 3d Half tolerance 37d Baseline ~60d
    ← Back to Methyprylon